Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?
Grubb
Robert L
RL
Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO 63110, USA.
Andriole
Gerald L
GL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality / Q000601:surgery*; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen